Related Experiment Video
Updated: Sep 18, 2025

Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
Murine astrovirus infection course and antibody response in different mouse strains
Jessica Seib1, Daniela Höfler2, Lena Hornetz3
1Microbiological Diagnostics, German Cancer Research Center, Heidelberg, Germany.
Abstract:
Monitoring the health of mice used in animal experiments constitutes an important instrument toward microbiological standardization, as infections can alter physiological parameters and immune reactions and may therefore have an essential impact on experimental outcome. In view of the high prevalence rates of murine astrovirus (MuAstV) infections in laboratory mouse facilities worldwide and the potential impact on research outcomes and reproducibility, there is a need to include MuAstV in the existing laboratory mice health monitoring programs. Here, to determine the sentinel strain and diagnostic method of choice, we aimed to assess the course of MuAstV infection and the resulting immune response in three immunocompetent mouse strains (Crl:CD1 (ICR), C57BL/6J and BALB/cOlaHsd) and one immunodeficient strain (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) by analyzing blood, feces and tissue samples with MuAstV-specific polymerase chain reaction and serology. Depending on the mouse strain, the duration of infection and viral load differed significantly, as well as the rapidity and quantity of antibody production. Virus shedding in immunocompetent mice was limited to a maximum of 4 weeks, whereas immunodeficient mice shed virus for the entire duration of this study. A fast antibody response with high titers was found only in outbred CD1 mice. In C57BL/6J and BALB/c mice, however, seropositivity and high antibody levels were reached only after the second infection. These results not only improve our understanding of the infection characteristics of MuAstV, presumably the most prevalent virus in laboratory mice, but also help to set up a health monitoring routine giving meaningful and reliable results on the MuAstV infection status of laboratory mouse populations.
Insights
Murine astrovirus (MuAstV) infections impact research. This study evaluated MuAstV infection in different mouse strains to improve health monitoring and ensure reliable experimental results.
Area of Science:
- Veterinary Microbiology
- Laboratory Animal Science
- Immunology
Background:
- Infections in laboratory mice, such as murine astrovirus (MuAstV), can significantly affect experimental outcomes and reproducibility.
- MuAstV is highly prevalent globally, necessitating its inclusion in routine health monitoring programs for laboratory mice.
Purpose of the Study:
- To assess the course of MuAstV infection and the host immune response in different mouse strains.
- To identify optimal sentinel strains and diagnostic methods for MuAstV detection in research settings.
Main Methods:
- Analysis of blood, feces, and tissue samples from immunocompetent (CD1, C57BL/6J, BALB/c) and immunodeficient (NOD.Cg-PrkdcscidIl2rg) mice.
- Utilized MuAstV-specific polymerase chain reaction (PCR) and serological assays to track infection and immune response.
Main Results:
- Significant variations in infection duration, viral load, and antibody production were observed across different mouse strains.
- Immunocompetent mice shed virus for up to 4 weeks; immunodeficient mice shed virus throughout the study.
- CD1 mice showed a rapid antibody response, while C57BL/6J and BALB/c mice required a second infection for seropositivity.
Conclusions:
- Understanding MuAstV infection dynamics in various mouse strains is crucial for accurate health monitoring.
- These findings aid in establishing reliable health monitoring routines for detecting MuAstV status in laboratory mouse populations, enhancing research integrity.
More Related Videos
07:07Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022